{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:40:43Z","timestamp":1760100043290},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,2,12]],"date-time":"2008-02-12T00:00:00Z","timestamp":1202774400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1038\/sj.bjc.6604240","type":"journal-article","created":{"date-parts":[[2008,2,12]],"date-time":"2008-02-12T09:17:34Z","timestamp":1202807854000},"page":"989-991","source":"Crossref","is-referenced-by-count":43,"title":["Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial"],"prefix":"10.1038","volume":"98","author":[{"given":"S M","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N R","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J E","family":"Manson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-M","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J E","family":"Buring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,12]]},"reference":[{"key":"BF6604240_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.294.1.47","volume":"294","author":"NR Cook","year":"2005","unstructured":"Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE (2005) Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 294: 47\u201355","journal-title":"JAMA"},{"key":"BF6604240_CR2","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1001\/jama.291.20.2488","volume":"291","author":"RN DuBois","year":"2004","unstructured":"DuBois RN (2004) Aspirin and breast cancer prevention: the estrogen connection. JAMA 291: 2488\u20132489","journal-title":"JAMA"},{"key":"BF6604240_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/sj.bjc.6602003","volume":"91","author":"LA Garcia Rodriguez","year":"2004","unstructured":"Garcia Rodriguez LA, Gonzalez-Perez A (2004) Risk of breast cancer among users of aspirin and other anti-inflammatory drugs. Br J Cancer 91: 525\u2013529","journal-title":"Br J Cancer"},{"key":"BF6604240_CR4","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/aje\/kwm195","volume":"166","author":"JK Gill","year":"2007","unstructured":"Gill JK, Maskarinec G, Wilkens LR, Pike MC, Henderson BE, Kolonel LN (2007) Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort. Am J Epidemiol 166: 1150\u20131158","journal-title":"Am J Epidemiol"},{"key":"BF6604240_CR5","first-page":"6096","volume":"63","author":"RE Harris","year":"2003","unstructured":"Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A (2003) Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res 63: 6096\u20136101","journal-title":"Cancer Res"},{"key":"BF6604240_CR6","doi-asserted-by":"publisher","first-page":"18563","DOI":"10.1074\/jbc.M010787200","volume":"276","author":"CH Liu","year":"2001","unstructured":"Liu CH, Chang SH, Narko K, Trifan OC, Wu MT, Smith E, Haudenschild C, Lane TF, Hla T (2001) Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 276: 18563\u201318569","journal-title":"J Biol Chem"},{"key":"BF6604240_CR7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/jnci\/dji140","volume":"97","author":"SF Marshall","year":"2005","unstructured":"Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK (2005) Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst 97: 805\u2013812","journal-title":"J Natl Cancer Inst"},{"key":"BF6604240_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1471-2407-5-159","volume":"5","author":"E Rahme","year":"2005","unstructured":"Rahme E, Ghosn J, Dasgupta K, Rajan R, Hudson M (2005) Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer. BMC Cancer 5: 159","journal-title":"BMC Cancer"},{"key":"BF6604240_CR9","doi-asserted-by":"crossref","unstructured":"Ready A, Velicer CM, McTiernan A, White E (2007) NSAID use and breast cancer risk in the VITAL cohort. Breast Cancer Res Treat; e-pub ahead of print","DOI":"10.1007\/s10549-007-9665-x"},{"key":"BF6604240_CR10","first-page":"632","volume":"62","author":"A Ristimaki","year":"2002","unstructured":"Ristimaki A, Sivula A, Lundin J, Lundin M, Salminen T, Haglund C, Joensuu H, Isola J (2002) Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 62: 632\u2013635","journal-title":"Cancer Res"},{"key":"BF6604240_CR11","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/jnci\/89.15.1152","volume":"89","author":"MT Ruffin 4th","year":"1997","unstructured":"Ruffin 4th MT, Krishnan K, Rock CL, Normolle D, Vaerten MA, Peters-Golden M, Crowell J, Kelloff G, Boland CR, Brenner DE (1997) Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose. J Natl Cancer Inst 89: 1152\u20131160","journal-title":"J Natl Cancer Inst"},{"key":"BF6604240_CR12","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1001\/jama.291.20.2433","volume":"291","author":"MB Terry","year":"2004","unstructured":"Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI (2004) Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA 291: 2433\u20132440","journal-title":"JAMA"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6604240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604240","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:31:34Z","timestamp":1684413094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6604240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,12]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["BF6604240"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6604240","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,12]]}}}